Status:
UNKNOWN
Probiotic Supplementation in Children Affected by Upper Respiratory Infections
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions:
Upper Respiratory Tract Infection
Eligibility:
All Genders
29-4 years
Phase:
NA
Brief Summary
The goal of this randomized non-pharmacological Intervention study is to evaluate the effects of probiotic supplements (Bifidobacterium breve M-16V, Bifidobacterium lactis HN019, Lactobacillus rhamnos...
Eligibility Criteria
Inclusion
- Access to the Emergency room with fever and upper respiratory tract infection
- Age \> 28 days and ≤ 4 years
- Signature of informed consent by parents or guardian
Exclusion
- Presence of pathologies associated with immunosuppression or ongoing immunosuppressant treatments
- Hospitalisation/hospitalisation
- Diarrhea at enrollment
- No signed informed consent
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06052540
Start Date
September 1 2021
End Date
June 30 2024
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122